AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...

Within the Sanofi antibody collaboration, LDL cholesterol reduction drug Praluent has seen a slow ... and also in combination with a long list of bispecific antibodies. While safety issues have ...

The cough and cold relief drugs brand from Procter and Gamble topped the list of Rx and OTC pharma brands by impressions ...

In May, Sanofi set the strictest price increase caps. The company committed not to increase the list price of existing drugs in the US by more than the rate of healthcare inflation and also plans ...

Among Sanofi’s rare disease drugs, new rare blood disorder drug Altuviiio ... Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys.

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the ... AbbVie ABBV and Sanofi SNY. Johnson & Johnson’s third-quarter results were strong as it beat ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report third-quarter results on Oct. 31, 2024. The Zacks ...